MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202527106057 A) filed by Jiangsu Hengrui Pharmaceuticals Co. , Ltd.; and Shanghai Hengrui Pharmaceutical Co. on November 03, 2025, for Anti-Tf Antibody And Anti-Tf Antibody-Drug Conjugate And Medical Use Thereof.
Inventors include Shi, Jinping Number; Xu, Shaoyu; Jin, Xinsheng; Li, Xun; and Ying, Hanxiao.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: The present invention relates to an anti-TF antibody and an anti-TF antibody-drug conjugate and a medical use thereof. Specifically, the present invention relates to an anti-TF antibody, and an anti-TF antibody-drug conjugate represented by general formula (Pc-L-Y- D), wherein the Pc is the anti-TF antibody, and L, Y, and n are as defined in the description.
Disclaimer: Curated by HT Syndication.
